Med Life SA published the transcript of its 9-month 2025 results conference call, held on November 14, 2025. The event featured key management including the CEO and Chairman of the Board, the CFO, the Deputy CEO and Board Member, and the Investor Relations Manager. During the call, management reviewed the company's financial and operational performance for the third quarter of 2025. They highlighted the continued organic growth of Med Life SA despite economic challenges in Romania, noting, "MetLife has grown organically quite strongly despite the economic downturn and at least a decrease of sales in retail and online in Romania, according to data that has been published," said the CEO. Key topics discussed included the prioritization of investments in hospitals and revenue-generating businesses over administrative facilities. The Deputy CEO addressed the status of the Banu Manta building, explaining that the company had deprioritized its conversion to office space in favor of hospital investments but intends to reconsider this starting next year. Management also announced the completion of several organic projects, notably the opening of a new operating theatre at the MedLife Craiova Hospital. The hospital's focus will shift increasingly to complex oncological surgeries, reflecting the patient profile. "The equipment used in the new operating rooms meet the highest technological standards, and the medical team consists of over 20 specialists," management emphasized. Discussions also touched on cost impacts related to VAT and the company's approach to pricing, with management stating there is "no intention to adjust prices by the end of this year," but price adjustments may be considered in the coming year. The full transcript can be accessed through the link below.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Med Life SA published the original content used to generate this news brief on November 17, 2025, and is solely responsible for the information contained therein.
Comments